Aug 12 (Reuters) - China-headquartered medical device

maker Kangji Medical said on Tuesday it had received a

go-private proposal from asset manager TPG-backed Knight Bidco,

valuing the firm at HK$11.17 billion ($1.42 billion).

Knight Bidco is an entity owned by TPG Knight Topco,

which is ultimately controlled by TPG and other parties.

Its offer price of HK$9.25 represents a premium of nearly

9.9% to Kangji's last closing price. If approved, then as part

of the deal the company would delist from the Hong Kong Stock

Exchange and become a wholly owned unit of the buying firm.

Founded in 2004 and based in Hangzhou, Kangji designs and

makes minimally invasive surgical instruments, serving hospitals

and distributors across China and overseas.

($1 = 7.8495 Hong Kong dollars)